Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001090822 | SCV001246561 | pathogenic | not provided | 2018-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002554821 | SCV003441113 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2023-06-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg2011*) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 871059). This premature translational stop signal has been observed in individual(s) with clinical features of Leber congenital amaurosis (PMID: 17564967, 31054281). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. |
Baylor Genetics | RCV003469281 | SCV004216641 | pathogenic | Bardet-Biedl syndrome 14 | 2023-05-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005012544 | SCV005630425 | pathogenic | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2024-06-03 | criteria provided, single submitter | clinical testing |